Hiremagalur N. Jayaram

Author

Indiana University – Purdue University Indianapolis

Also Known As

H N Jayaram, H. Jayaram, H. N. Jayaram, H.N. Jayaram, HIREMAGALUR N. JAYARAM, Hiremagalur Jayaram, Hiremagalur N Jayaram, Hiremagalur N. JAYARAM, Hiremagalur N. Jayaram, Laurent Bonnac

138

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Richard L. Roudebush VA Medical Center National Cancer Institute National Institutes of Health

About

Hiremagalur N. Jayaram is an author at Indiana University – Purdue University Indianapolis specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	52	2K
2	Biochemistry	26	40	1.8K
3	Natural Sciences	23	28	1.4K
4	Health Sciences	3	3	75
5	Engineering	2	2	47

Hiremagalur N. Jayaram

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide NSC 286193) Hiremagalur N. Jayaram, Robert L. Dion, Robert I. Glazer, Biochemical Pharmacology Medicinal ChemistryInitial StudiesBiochemistryNew Oncolytic ThiazoleNatural Sciences	1982	144
Consequences of IMP Dehydrogenase Inhibition, and its Relationship to Cancer and Apoptosis Hiremagalur N. Jayaram, Michael Grusch, David A. Cooney, Current Medicinal Chemistry	1999	134
Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity. Guido Tricot, Hiremagalur N. Jayaram, Elizabeth Lapis, PubMed Mixed-phenotype Acute LeukemiaPharmacotherapyChemical BiologyPharmaceutical ChemistryMyeloid Neoplasia	1989	127
The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties David A. Cooney, Hiremagalur N. Jayaram, Gulilat Gebeyehu, Biochemical Pharmacology Medicinal ChemistryBiochemistryNatural SciencesBiocatalysisMedicine	1982	121
Conversion of 2-β-D-ribofuranosylselenazole-4-carboxamide to an analogue of nad with potent imp dehydrogenase-inhibitory properties Hiremagalur N. Jayaram, Gurpreet S. Ahluwalia, Robert L. Dion, Biochemical Pharmacology Medicinal ChemistryBiochemistryNatural SciencesBiocatalysisMedicine	1983	104
Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogs. Synthesis, structure, and interactions with IMP dehydrogenase Gulilat Gebeyehu, Víctor E. Márquez, Anne Van Cott, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiosynthesisNucleic Acid ChemistryBiochemistry	1985	91
Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside Michael Grusch, Doris Polgar, S Gfatter, Cell Death and Differentiation BiochemistryMedicineApoptosisPhysiologyBenzamide Riboside	2002	78
Synthesis, Structure, and Antiproliferative Activity of Selenophenfurin, an Inosine 5‘-Monophosphate Dehydrogenase Inhibitor Analogue of Selenazofurin Palmarisa Franchetti, Loredana Cappellacci, Ghassan Abu Sheikha, Journal of Medicinal Chemistry Medicinal ChemistryBioorganic ChemistryChemoprevention StrategyBiochemistryAntiproliferative Activity	1997	75
Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil. Bach Ardalan, David A. Cooney, Hiremagalur N. Jayaram, PubMed PathologyBiochemical BasisMurine TumorsTumor BiologyDrug Resistance	1980	70
Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions Asok Antony, Ying-Sheng Tang, Rehana A. Khan, Journal of Clinical Investigation	2004	64

Page 1